Literature DB >> 15112252

Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.

Hong-Ping Yu1, Shun-Qing Xu, Wen-Hong Lu, Yuan-Yuan Li, Fang Li, Xiao-Li Wang, Yan-Hua Su.   

Abstract

BACKGROUND: Telomerase maintains telomere length and is considered to be necessary for the indefinite proliferation of human cells. Activation of telomerase plays a key role in the malignant transformation process. The aim of this study was to study the regulation of telomerase, and to explore the possibility of telomerase as a biomarker in squamous carcinogenesis of the esophagus.
METHODS: Twenty-nine esophageal squamous cell carcinomas (ESCC) and its corresponding adjacent normal tissues, and 47 epithelial squamous dysplasia tissues were analyzed by the reverse transcriptase-polymerase chain reaction (RT-PCR) technique for the mRNA expression of three major telomerase subunits: human telomerase RNA (hTR), telomerase protein component 1 (TP1), and human telomerase reverse transcriptase (hTERT) and by telomeric repeat amplification protocol assay (TRAP) for telomerase activity.
RESULTS: For the expression of hTR and TP1 mRNA, there were no significant differences among ESCC, dysplasia and normal tissues (P > 0.05). In contrast, hTERT mRNA expression was detected in 28 of 29 ESCC (96.6%), in 23 of 47 dysplasia (48.9%), and only in two of 29 normal tissues (7.5%). Telomerase activity was positive in 25 of 29 ESCC (86.2%), in 21 of 47 (44.7%) epithelial dysplasia tissues, and in none of normal tissue. All together, 95 of 105 cases (90.48%) were concordant for both results, i.e., telomerase activity positive and hTERT positive or telomerase activity negative and hTERT negative tissues, and telomerase activity correlated with hTERT mRNA expression (P < 0.001).
CONCLUSIONS: Higher telomerase activity and hTERT mRNA expression were shown during an early stage in the esophageal carcinogenesis. Activation of telomerase activity was strongly correlated with hTERT mRNA expression, suggesting hTERT is a major regulator of telomerase activity, and telomerase activation may play a critical role in esophageal carcinogenesis. Therefore, telomerase, especially hTERT can be used as a potential molecular biomarker of ESCC. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112252     DOI: 10.1002/jso.20050

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  10 in total

1.  Biological significance of PinX1 telomerase inhibitor in esophageal carcinoma treatment.

Authors:  Xiang-Kui Fan; Rui-Hua Yan; Xiang-Qun Geng; Jing-Shan Li; Xiang-Ming Chen; Jian-Zhe Li
Journal:  Exp Ther Med       Date:  2016-08-01       Impact factor: 2.447

2.  Treatment of radioresistant stem-like esophageal cancer cells by an apoptotic gene-armed, telomerase-specific oncolytic adenovirus.

Authors:  Xiaochun Zhang; Ritsuko Komaki; Li Wang; Bingliang Fang; Joe Y Chang
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

3.  Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.

Authors:  Z Qi; R Mi
Journal:  Cancer Gene Ther       Date:  2016-01-08       Impact factor: 5.987

Review 4.  Telomeres and telomere dynamics: relevance to cancers of the GI tract.

Authors:  Nivedita Basu; Halcyon G Skinner; Kristin Litzelman; Russell Vanderboom; Esha Baichoo; Lisa A Boardman
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2013-11       Impact factor: 3.869

5.  Antisense oligodeoxynucleotide against human telomerase reverse transcriptase inhibits the proliferation of Eca-109 esophageal carcinoma cells.

Authors:  Xiang-Kui Fan; Rui-Hua Yan; Bao-Jiang Li; Xiang-Ming Chen; Lin Wei; Zhou Wang
Journal:  Exp Ther Med       Date:  2014-08-11       Impact factor: 2.447

6.  The identification of two regulatory ESCC susceptibility genetic variants in the TERT-CLPTM1L loci.

Authors:  Liqing Zhou; Guobin Fu; Jinyu Wei; Juan Shi; Wenting Pan; Yanli Ren; Xiangyu Xiong; Jianhong Xia; Yue Shen; Hongliang Li; Ming Yang
Journal:  Oncotarget       Date:  2016-02-02

7.  Azidothymidine inhibits cell growth and telomerase activity and induces DNA damage in human esophageal cancer.

Authors:  Haoli Wang; Jianwen Zhou; Qiong He; Yu Dong; Yanhui Liu
Journal:  Mol Med Rep       Date:  2017-05-03       Impact factor: 2.952

Review 8.  Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.

Authors:  Hao Li; Tao Yu Diao; Zhi Ying Zhou; Fang Yan Yang; Qing Ma; Qing Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2009-11-25

9.  Change of the expression of human telomerase reverse transcriptase mRNA and human telomerase RNA after cisplatin and 5-fluorouracil exposure in head and neck squamous cell carcinoma cell lines.

Authors:  Byung Joo Lee; Bae Hyuk Lee; Soo Geun Wang; Jin Choon Lee; Hwan Jung Roh; Eui Kyung Goh; Cheol Min Kim; Eun Sook Jun
Journal:  J Korean Med Sci       Date:  2007-09       Impact factor: 2.153

Review 10.  Variations in telomere maintenance and the role of telomerase inhibition in gastrointestinal cancer.

Authors:  Steffen Heeg
Journal:  Pharmgenomics Pers Med       Date:  2015-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.